A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy

NCT00476151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy
Neuralgia

Interventions

DRUG: EpiCept NP-1 (4% Amitriptyline/ 2% Ketamine) Topical Cream
DRUG: placebo cream

Sponsor

EpiCept Corporation